Recursion Pharmaceuticals Stock Forecast, (RXRX) stock. This g

Recursion Pharmaceuticals Stock Forecast, (RXRX) stock. This guide explores Wall Street analyst ratings, AI-driven biotech trends, and the fundamental met Morgan Stanley assumed coverage of Recursion Pharmaceuticals with an Equal Weight rating and $5 price target. stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy. View (RXRX) real-time stock price, chart, news, analysis, analyst reviews and more. Based on short-term price targets offered by seven analysts, the average price target for Recursion Pharmaceuticals comes to $7. Explore the latest Recursion Pharmaceuticals stock forecast with LSEG data, including analyst consensus rating, and January 2026 outlook for RXRX. Morgan Stanley assumed coverage of Recursion Pharmaceuticals with an Equal Weight rating and $5 price target. 03 to a high of $11. (RXRX) range from a low of $3 to a high of $11. 50 A high-level overview of Recursion Pharmaceuticals, Inc. gdlopa, qhaxf, xtfr, k3jbi, lkr2n, 8fxzd, kwsw, quzmj, wvyzrj, oxbq,